MELIOR DISCOVERY, INC

Profile

Company Names

MELIOR DISCOVERY, INC

Addresses

860 SPRINGDALE DRIVE, SUITE 500, EXTON, PA 19341

860 SPRINGDALE DRIVE, EXTON, PA 19341

Phone Numbers

610-280-0633

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2005

State Incorporated:

DELAWARE

Total Amount Raised:

$2,816,599.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2013-01-22 
$1,741,599.00 
$3,838,524.00 
$2,096,925.00 
Equity 
2
2009-09-10 
$825,000.00 
$5,000,000.00 
$4,175,000.00 
Equity 
1
2009-07-16 
$250,000.00 
$250,000.00 
$0.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROBERT 
 
ADELSON 
DIRECTOR
MELIOR DISCOVERY, INC   |  MELIOR PHARMACEUTICALS I, INC.   |  SEVONE INC   |  CIMARRON HEALTHCARE INVESTMENTS I, LP   |  HALFPENNY TECHNOLOGIES, INC.   |  RESOLVE DIGITAL HEALTH INC   |  EMBODIED, INC.   |  PLIANT.IO, INC.   |  TRULITE HEALTH, INC.
ROBERT 
S 
ADELSON 
DIRECTOR
MELIOR DISCOVERY, INC   |  COLLECTIONS MARKETING CENTER, INC.
JOHN 
 
FARAH 
DIRECTOR
AEOLUS PHARMACEUTICALS, INC.   |  GENSPERA INC   |  MELIOR DISCOVERY, INC
JEFFREY 
 
HANDLER 
EXECUTIVE OFFICER, DIRECTOR
MELIOR DISCOVERY, INC
ROBERT 
 
IMERSHEIN 
DIRECTOR
MELIOR DISCOVERY, INC
DONALD 
 
MARVIN 
DIRECTOR
MELIOR DISCOVERY, INC   |  NUME HEALTH, LLC
TOBY 
 
MOSKOVITS 
DIRECTOR
MELIOR DISCOVERY, INC   |  MELIOR PHARMACEUTICALS I, INC.
TOBY 
 
MOSKOWITZ 
DIRECTOR
MELIOR DISCOVERY, INC
ANDREW 
 
REAUME 
EXECUTIVE OFFICER, DIRECTOR
MELIOR DISCOVERY, INC   |  MELIOR PHARMACEUTICALS I, INC.
MICHAEL 
 
SAPORITO 
DIRECTOR
MELIOR DISCOVERY, INC   |  MELIOR PHARMACEUTICALS I, INC.
MICHAEL 
S. 
SAPORITO 
EXECUTIVE OFFICER
MELIOR DISCOVERY, INC
MICHAEL 
 
SAPPORITO 
EXECUTIVE OFFICER, DIRECTOR
MELIOR DISCOVERY, INC
JEFFRY 
 
VAUGHT 
DIRECTOR
MELIOR DISCOVERY, INC
BOBBA 
 
VENKATADRI 
DIRECTOR
MELIOR DISCOVERY, INC   |  MELIOR PHARMACEUTICALS I, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2013-02-06
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-01-22 
2009-09-24
D
Link
PHARMACEUTICALS 
 
$5,000,001 - $25,000,000 
Equity 
2009-09-10 
2009-07-30
D
Link
PHARMACEUTICALS 
 
$5,000,001 - $25,000,000 
Debt 
2009-07-16 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#